Skip to main content
. 2019 Jul 10;7(8):2451–2470. doi: 10.1002/fsn3.1117

Table 3.

Associations between garlic consumption and cardiovascular and inflammatory outcomes

Outcome Author Year Type of allium vegetables Dose Population Type of studies in MA No. Of trials and participants in MA Duration Metric of MA Units Effects model Effect size (95% CI) I 2%a Publication bias
Systolic blood pressure Ried, K. 2016 Garlic (powder, extract, or oil) Median: 900 mg/day (range 12.3–3,050) Both normotensive and hypertensive participants Interventional studies 19; 908 Median: 12 weeks (range 2–24) WMD mmHg REM −5.07 (−7.30, −2.85) 71.0 NR
Diastolic blood pressure Ried, K. 2016 Garlic (powder, extract, or oil) Median: 900 mg/day (range 12.3–3,050) Both normotensive and hypertensive participants Interventional studies 20; 972 Median: 12 weeks (range 2–24) WMD mmHg REM −2.48 (−4.07, −0.89) 72.0 NR
Systolic blood pressure Ried, K. 2016 Garlic (powder, extract, or oil) Median: 900 mg/day (range 12.3–3,050) Hypertensive participants Interventional studies 10; 468 Median: 12 weeks (range 2–24) WMD mmHg REM −8.35 (−10.58, −6.11) 48.0 NR
Diastolic blood pressure Rohner, A., et al 2015 Garlic (powder, extract) Median: 600 mg/day (range 188–960) Hypertensive participants Interventional studies 9; 482 Median: 12 weeks (range 8–26) WMD mmHg REM −3.82 (−6.69, −0.96) 80.0 Noneb
Systolic blood pressure Ried, K. 2016 Garlic (powder, extract, or oil) Median: 900 mg/day (range 12.3–3,050) Normotensive participants Interventional studies 11; 468 Median: 12 weeks (range 2–24) WMD mmHg REM −1.50 (−3.40, 0.40) NR NR
Diastolic blood pressure Ried, K. 2016 Garlic (powder, extract, or oil) Median: 900 mg/day (range 12.3–3,050) Normotensive participants Interventional studies 14; 641 Median: 12 weeks (range 2–24) WMD mmHg REM −0.40 (−1.60, 0.80) NR NR
C‐reactive protein level Taghizadeh, M., et al 2018 Garlic and garlic supplement Median: 2,100 mg/day (range 250–3,600) Healthy participants or patients of diabetes and coronary artery disease Interventional studies 9; 348 Median: 12 weeks (range 2–48) WMD mg/L REM −0.80 (−1.50, −0.10) 98.0 0.34c

95% CI, 95% confidence intervals; MA, meta‐analysis; NR, not reported; REM, random effects model; WMD, weighted mean differences.

a

Heterogeneity was assessed with I 2 statistic.

b

Assessed by funnel chart.

c

Assessed by Egger's regression test.